Skip to main content
Blood Advances logoLink to Blood Advances
. 2021 Jun 17;5(12):2576. doi: 10.1182/bloodadvances.2021005072

Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.

PMCID: PMC8267111  PMID: 34137814

In the author affiliations on page 3141, affiliation 1 should read “National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China.” The error has been corrected in the published article.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES